“…Some studies have reported serum anti-ganglioside antibodies in NA patients, however it is still unclear whether these are actually involved in the pathogenesis of NA (3,21). In particular, the anti-GalNAc-GD1a antibody was reported as a candidate biological marker for predicting response to immune therapy (14).…”